Q2 2021 reporting is picking up pace as many companies will release their numbers in the next two weeks (last week of July and first week of August). As our Kieger AG Chart Of The Month shows, consensus Q2 EPS expectations in the healthcare sector have recently (1m) risen only marginally compared to the broader market, which could leave room for positive surprises.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.